{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:32:52Z","timestamp":1794886372343,"version":"4.9.1"},"reference-count":106,"publisher":"IOP Publishing","issue":"31","license":[{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/iop-standard\/v1"},{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/info\/page\/text-and-data-mining"}],"content-domain":{"domain":["iopscience.iop.org"],"crossmark-restriction":false},"short-container-title":["Nanotechnology"],"published-print":{"date-parts":[[2022,7,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Single chain variable D2B antibody fragments (scFvD2Bs) exhibit high affinity binding to prostate specific membrane antigens overexpressed in metastatic prostate cancer (PC). Conjugation of scFvD2B to gold nanoparticles (AuNPs) would enhance its stability and plasma half-life circulation to shuttle theranostic agents in PC. In this study, we synthesized PEGylated scFvD2B-AuNPs (AuNPs-scFvD2B-PEG) and tested their integrity, biocompatibility, and immunogenicity in freshly withdrawn human blood. Prior to blood incubation, Zeta potential measurements, UV\u2013Vis spectroscopy, and dynamic light scattering (DLS) were used to assess the physicochemical properties of our nano-complexes in the presence or absence of PEGylation. A surface plasmon resonance band shift of 2 and 4 nm confirmed the successful coating for AuNPs-scFvD2B and AuNPs-scFvD2B-PEG, respectively. Likewise, DLS revealed a size increase of \u223c3 nm for AuNPs-scFvD2B and \u223c19 nm for AuNPs-scFvD2B-PEG. Zeta potential increased from \u221234 to \u221219 mV for AuNPs-scFvD2B and reached \u22123 mV upon PEGylation. Similar assessment measures were applied\u00a0post-incubation in human blood with additional immunogenicity tests, such as hemolysis assay, neutrophil function test, and pyridine formazan extraction. Interestingly, grafting PEG chains on AuNPs-scFvD2B precluded the binding of blood plasma proteins and reduced neutrophil activation level compared with naked AuNPs-citrate counterparts. Most likely, a hydrated negative PEG cloud shielded the NPs rendering blood compatiblility with less than 10% hemolysis. In conclusion, the biocompatible AuNPs-scFvD2B-PEG presents promising characteristics for PC targeted therapy, with minimal protein adsorption affinity, low immunorecognition, and reduced hemolytic activity.<\/jats:p>","DOI":"10.1088\/1361-6528\/ac66ef","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T18:11:51Z","timestamp":1649873511000},"page":"315101","update-policy":"https:\/\/doi.org\/10.1088\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Human blood biocompatibility and immunogenicity of scFvD2B PEGylated gold nanoparticles"],"prefix":"10.1088","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3059-7189","authenticated-orcid":true,"given":"Nadim","family":"Mitri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Rahme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3024-0307","authenticated-orcid":true,"given":"Giulio","family":"Fracasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8770-0880","authenticated-orcid":false,"given":"Esther","family":"Ghanem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"266","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"key":"nanoac66efbib1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1001\/archfami.2.5.487","type":"journal-article","article-title":"A structured literature review of treatment for localized prostate cancer. Prostate disease patient outcome research team","volume":"2","author":"Wasson","year":"1993","journal-title":"Arch. Family Med."},{"key":"nanoac66efbib2","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1001\/jama.2017.7248","type":"journal-article","article-title":"The diagnosis and treatment of prostate cancer: a review","volume":"317","author":"Litwin","year":"2017","journal-title":"JAMA"},{"key":"nanoac66efbib3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/1097-0045(20001201)45:4<350::AID-PROS10>3.0.CO;2-U","type":"journal-article","article-title":"Prostate-specific membrane antigen (PSMA) enzyme activity is elevated in prostate cancer cells","volume":"45","author":"Lapidus","year":"2000","journal-title":"Prostate"},{"key":"nanoac66efbib4","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/S0090-4295(01)00983-9","type":"journal-article","article-title":"Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma","volume":"57","author":"Chang","year":"2001","journal-title":"Urology"},{"key":"nanoac66efbib5","first-page":"6357","type":"journal-article","article-title":"Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer","volume":"9","author":"Ross","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"nanoac66efbib6","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.1091\/mbc.e02-11-0731","type":"journal-article","article-title":"A novel cytoplasmic tail MXXXL motif mediates the internalization of prostate-specific membrane antigen","volume":"14","author":"Rajasekaran","year":"2003","journal-title":"Mol. Biol. Cell."},{"key":"nanoac66efbib7","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1097\/01.ju.0000091655.77601.0c","type":"journal-article","article-title":"Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen","volume":"170","author":"Bander","year":"2003","journal-title":"J. Urol."},{"key":"nanoac66efbib8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.urolonc.2013.09.003","type":"journal-article","article-title":"The prostate-specific membrane antigen: lessons and current clinical implications from 20 years of research","volume":"32","author":"Ristau","year":"2014","journal-title":"Urologic Oncol."},{"key":"nanoac66efbib9","doi-asserted-by":"publisher","first-page":"e4608","DOI":"10.1371\/journal.pone.0004608","type":"journal-article","article-title":"The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumour cells by activating the MAPK pathways","volume":"4","author":"Colombatti","year":"2009","journal-title":"PLoS One"},{"key":"nanoac66efbib10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/cmmi.1596","type":"journal-article","article-title":"Targeting human prostate cancer with 111In-labeled D2B IgG, F(ab\u2019)2 and Fab fragments in nude mice with PSMA-expressing xenografts","volume":"10","author":"Lutje","year":"2015","journal-title":"Contrast Media Mol. Imaging"},{"key":"nanoac66efbib11","first-page":"81","type":"journal-article","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","author":"Silver","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"nanoac66efbib12","first-page":"2321","type":"journal-article","article-title":"Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hybridization","volume":"57","author":"Kawakami","year":"1997","journal-title":"Cancer Res."},{"key":"nanoac66efbib13","first-page":"4055","type":"journal-article","article-title":"Constitutive and antibody-induced internalization of prostate-specific membrane antigen","volume":"58","author":"Liu","year":"1998","journal-title":"Cancer Res."},{"key":"nanoac66efbib14","doi-asserted-by":"publisher","first-page":"995","DOI":"10.2967\/jnumed.114.138180","type":"journal-article","article-title":"Dual-modality image-guided surgery of prostate cancer with a radiolabeled fluorescent anti-PSMA monoclonal antibody","volume":"55","author":"Lutje","year":"2014","journal-title":"J. Nucl. Med."},{"key":"nanoac66efbib15","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1016\/j.ejca.2013.01.024","type":"journal-article","article-title":"A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer","volume":"49","author":"Frigerio","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"nanoac66efbib16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.imlet.2015.09.012","type":"journal-article","article-title":"Effect of radiochemical modification on biodistribution of scFvD2B antibody fragment recognising prostate specific membrane antigen","volume":"168","author":"Frigerio","year":"2015","journal-title":"Immunol Lett."},{"key":"nanoac66efbib17","doi-asserted-by":"publisher","first-page":"10919","DOI":"10.18632\/oncotarget.14229","type":"journal-article","article-title":"Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging","volume":"8","author":"Frigerio","year":"2017","journal-title":"Oncotarget"},{"key":"nanoac66efbib18","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1002\/smll.201201196","type":"journal-article","article-title":"Plasmonic nanostructures for SERRS multiplexed identification of tumor-associated antigens","volume":"8","author":"Meneghetti","year":"2012","journal-title":"Small"},{"key":"nanoac66efbib19","doi-asserted-by":"publisher","first-page":"8821","DOI":"10.1039\/C7TB02464A","type":"journal-article","article-title":"Targeted killing of prostate cancer cells using antibody\u2013drug conjugated carbon nanohorns","volume":"5","author":"Luc\u00edo","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"nanoac66efbib20","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.3390\/ma13173875","type":"journal-article","article-title":"Design and evaluation of (223)Ra-labeled and anti-PSMA targeted NaA nanozeolites for prostate cancer therapy-part I","volume":"13","author":"Czerwi\u0144ska","year":"2020","journal-title":"Materials (Basel, Switzerland)"},{"key":"nanoac66efbib21","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1039\/C7NR07844G","type":"journal-article","article-title":"Safe core-satellite magneto-plasmonic nanostructures for efficient targeting and photothermal treatment of tumor cells","volume":"10","author":"Bertorelle","year":"2018","journal-title":"Nanoscale."},{"key":"nanoac66efbib22","doi-asserted-by":"publisher","first-page":"e109427","DOI":"10.1371\/journal.pone.0109427","type":"journal-article","article-title":"PSMA-specific CAR-engineered T cells eradicate disseminated prostate cancer in preclinical models","volume":"9","author":"Zuccolotto","year":"2014","journal-title":"PLoS One"},{"key":"nanoac66efbib23","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3390\/cells9061382","type":"journal-article","article-title":"Anti-PSMA CAR-engineered NK-92 cells: an off-the-shelf cell therapy for prostate cancer","volume":"9","author":"Montagner","year":"2020","journal-title":"Cells"},{"key":"nanoac66efbib24","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1158\/1535-7163.MCT-10-1093","type":"journal-article","article-title":"Induction of in vitro and in vivo NK cell cytotoxicity using high-avidity immunoligands targeting prostate-specific membrane antigen in prostate carcinoma","volume":"10","author":"Jachimowicz","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"nanoac66efbib25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-3-319-22942-3_6","type":"journal-article","article-title":"Gold-based nanomaterials for applications in nanomedicine","volume":"370","author":"Ashraf","year":"2016","journal-title":"Top. Curr. Chem."},{"key":"nanoac66efbib26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.32607\/20758251-2011-3-2-34-55","type":"journal-article","article-title":"Gold nanoparticles in biology and medicine: recent advances and prospects","volume":"3","author":"Dykman","year":"2011","journal-title":"Acta Nat."},{"key":"nanoac66efbib27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1259\/bjr\/59448833","type":"journal-article","article-title":"Gold nanoparticles as novel agents for cancer therapy","volume":"85","author":"Jain","year":"2012","journal-title":"Br. J. Radiol."},{"key":"nanoac66efbib28","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1517\/17425247.2014.891582","type":"journal-article","article-title":"Gold nanoparticle conjugates: recent advances toward clinical applications","volume":"11","author":"Cao-Milan","year":"2014","journal-title":"Exp. Opin. Drug Delivery."},{"key":"nanoac66efbib29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2147\/NSA.S8984","type":"journal-article","article-title":"Functionalized gold nanoparticles for the binding, stabilization, and delivery of therapeutic DNA, RNA, and other biological macromolecules","volume":"3","author":"Delong","year":"2010","journal-title":"Nanotechnol. Sci. Appl."},{"key":"nanoac66efbib30","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1039\/C0CS00018C","type":"journal-article","article-title":"Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies","volume":"40","author":"Khlebtsov","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"nanoac66efbib31","doi-asserted-by":"publisher","first-page":"035008","DOI":"10.1088\/2043-6262\/ac2747","type":"journal-article","article-title":"D2B antibody and its scFvD2B fragment in nanomedicine: promising tools in the theranostics of prostate cancer","volume":"12","author":"Mitri","year":"2021","journal-title":"Adv. Nat. Sci.: Nanosci. Nanotechnol."},{"key":"nanoac66efbib32","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.69386","type":"book","article-title":"Interaction of nanoparticles with blood components and associated pathophysiological effects","author":"De La Cruz","year":"2018"},{"key":"nanoac66efbib33","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0950-3536(05)80139-8","type":"journal-article","article-title":"Neutrophil function tests","volume":"3","author":"Haynes","year":"1990","journal-title":"Bailliere\u2019s Clin. Haematol."},{"key":"nanoac66efbib34","doi-asserted-by":"publisher","first-page":"9301912","DOI":"10.1155\/2018\/9301912","type":"journal-article","article-title":"Assessment of charged AuNPs: from synthesis to innate immune recognition","volume":"2018","author":"Rahme","year":"2018","journal-title":"J. Nanomater."},{"key":"nanoac66efbib35","doi-asserted-by":"publisher","first-page":"e1004651","DOI":"10.1371\/journal.ppat.1004651","type":"journal-article","article-title":"Neutrophils: between host defence, immune modulation, and tissue injury","volume":"11","author":"Kruger","year":"2015","journal-title":"PLoS Pathogens"},{"key":"nanoac66efbib36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2006.09.030","type":"journal-article","article-title":"Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function","volume":"42","author":"Fialkow","year":"2007","journal-title":"Free Rad. Biol. Med."},{"key":"nanoac66efbib37","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","type":"journal-article","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"nanoac66efbib38","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.vetpar.2010.04.024","type":"journal-article","article-title":"The nitroblue tetrazolium reduction test in canine leishmaniosis","volume":"172","author":"G\u00f3mez-Ochoa","year":"2010","journal-title":"Veterinary Parasitol."},{"key":"nanoac66efbib39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.vetimm.2012.01.018","type":"journal-article","article-title":"Use of the nitroblue tetrazolium reduction test for the evaluation of Domperidone effects on the neutrophilic function of healthy dogs","volume":"146","author":"G\u00f3mez-Ochoa","year":"2012","journal-title":"Vet Immunol Immunopathol."},{"key":"nanoac66efbib40","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1172\/JCI106156","type":"journal-article","article-title":"Failure of nitro blue tetrazolium reduction in the phagocytic vacuoles of leukocytes in chronic granulomatous disease","volume":"48","author":"Nathan","year":"1969","journal-title":"J. Clin. Invest."},{"key":"nanoac66efbib41","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/cyto.990110809","type":"journal-article","article-title":"Flow cytometric evaluation of nitro blue tetrazolium (NBT) reduction in human polymorphonuclear leukocytes","volume":"11","author":"Fattorossi","year":"1990","journal-title":"Cytometry"},{"key":"nanoac66efbib42","first-page":"309","type":"journal-article","article-title":"Cell damage and dye reduction in the quantitative nitroblue tetrazolium (NBT) test","volume":"19","author":"Segal","year":"1975","journal-title":"Clin. Exp. Immunol."},{"key":"nanoac66efbib43","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1039\/C3MH00106G","type":"journal-article","article-title":"Protein corona formation around nanoparticles\u2014from the past to the future","volume":"1","author":"Pino","year":"2014","journal-title":"Mater. Horiz."},{"key":"nanoac66efbib44","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1021\/nn3059295","type":"journal-article","article-title":"Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge","volume":"7","author":"H\u00fchn","year":"2013","journal-title":"ACS Nano"},{"key":"nanoac66efbib45","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3390\/nano11040888","type":"journal-article","article-title":"Hard and soft protein corona of nanomaterials: analysis and relevance","volume":"11","author":"Garc\u00eda-\u00c1lvarez","year":"2021","journal-title":"Nanomaterials"},{"key":"nanoac66efbib46","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1021\/ed054p560","type":"journal-article","article-title":"SDS-polyacrylamide gel electrophoresis. A simple explanation of why it works","volume":"54","author":"Svasti","year":"1977","journal-title":"J. Chem. Educ."},{"key":"nanoac66efbib47","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1021\/nl0805615","type":"journal-article","article-title":"Method for analysis of nanoparticle hemolytic properties in vitro","volume":"8","author":"Dobrovolskaia","year":"2008","journal-title":"Nano Lett."},{"key":"nanoac66efbib48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.tox.2009.01.015","type":"journal-article","article-title":"The role of nanoparticle size in hemocompatibility","volume":"258","author":"Mayer","year":"2009","journal-title":"Toxicology"},{"key":"nanoac66efbib49","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.ijbiomac.2015.11.031","type":"journal-article","article-title":"Dibutyrylchitin nanoparticles as novel drug carrier","volume":"82","author":"Jain","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"nanoac66efbib50","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.1158\/1078-0432.CCR-10-0978","type":"journal-article","article-title":"Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine","volume":"16","author":"Libutti","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"nanoac66efbib51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","type":"journal-article","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Delivery Rev."},{"key":"nanoac66efbib52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0014-5793(90)81016-H","type":"journal-article","article-title":"Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes","volume":"268","author":"Klibanov","year":"1990","journal-title":"FEBS Lett."},{"key":"nanoac66efbib53","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1126\/science.8128245","type":"journal-article","article-title":"Biodegradable long-circulating polymeric nanospheres","volume":"263","author":"Gref","year":"1994","journal-title":"Science"},{"key":"nanoac66efbib54","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1743-8977-11-26","type":"journal-article","article-title":"Pharmacokinetics, clearance, and biosafety of polyethylene glycol-coated hollow gold nanospheres","volume":"11","author":"You","year":"2014","journal-title":"Part. Fibre Toxicol."},{"key":"nanoac66efbib55","doi-asserted-by":"publisher","first-page":"6811","DOI":"10.1016\/j.biomaterials.2005.04.063","type":"journal-article","article-title":"Endotoxin: the uninvited guest","volume":"26","author":"Gorbet","year":"2005","journal-title":"Biomaterials"},{"key":"nanoac66efbib56","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3389\/fimmu.2017.00472","type":"journal-article","article-title":"Endotoxin contamination in nanomaterials leads to the misinterpretation of immunosafety results","volume":"8","author":"Li","year":"2017","journal-title":"Front. Immunol."},{"key":"nanoac66efbib57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-1-4939-7352-1_3","type":"book","article-title":"Considerations and some practical solutions to overcome nanoparticle interference with LAL assays and to avoid endotoxin contamination in nanoformulations","author":"Neun","year":"1682"},{"key":"nanoac66efbib58","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/smll.200901006","type":"journal-article","article-title":"Sterilization matters: consequences of different sterilization techniques on gold nanoparticles","volume":"6","author":"Fran\u00e7a","year":"2010","journal-title":"Small"},{"key":"nanoac66efbib59","author":"Rubinstein","year":"2003","type":"book"},{"key":"nanoac66efbib60","doi-asserted-by":"publisher","first-page":"e50166","DOI":"10.3791\/50166","type":"journal-article","article-title":"Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs","volume":"73","author":"Evans","year":"2013","journal-title":"J. Vis. Exp."},{"key":"nanoac66efbib61","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1039\/C3RA45345F","type":"journal-article","article-title":"Curcumin conjugated gold nanoparticle synthesis and its biocompatibility","volume":"4","author":"Sindhu","year":"2014","journal-title":"RSC Adv."},{"key":"nanoac66efbib62","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.sbsr.2016.04.002","type":"journal-article","article-title":"Various methods of gold nanoparticles (GNPs) conjugation to antibodies","volume":"9","author":"Jazayeri","year":"2016","journal-title":"Sens. Bio-Sens. Res."},{"key":"nanoac66efbib63","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3109\/17435390903471463","type":"journal-article","article-title":"Gold nanoparticles cellular toxicity and recovery: effect of size, concentration and exposure time","volume":"4","author":"Mironava","year":"2010","journal-title":"Nanotoxicology"},{"key":"nanoac66efbib64","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/nano7060123","type":"journal-article","article-title":"Curcuma mangga-mediated synthesis of gold nanoparticles: characterization, stability, cytotoxicity, and blood compatibility","volume":"7","author":"Foo","year":"2017","journal-title":"Nanomaterials"},{"key":"nanoac66efbib65","doi-asserted-by":"publisher","first-page":"203002","DOI":"10.1088\/1361-648X\/aa60f3","type":"journal-article","article-title":"Surface plasmon resonance in gold nanoparticles: a review","volume":"29","author":"Amendola","year":"2017","journal-title":"J. Phys.: Condens. Matter."},{"key":"nanoac66efbib66","doi-asserted-by":"publisher","first-page":"025009","DOI":"10.1088\/2043-6254\/1\/2\/025009","type":"journal-article","article-title":"Synthesis, capping and binding of colloidal gold nanoparticles to proteins","volume":"1","author":"Nghiem","year":"2010","journal-title":"Adv. Nat. Sci.: Nanosci. Nanotechnol."},{"key":"nanoac66efbib67","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1590\/S0103-97332010000200021","type":"journal-article","article-title":"Effect of particle size on nonlinear refractive index of Au nanoparticle in PVA solution","volume":"40","author":"Shahriari","year":"2010","journal-title":"Braz. J. Phys."},{"key":"nanoac66efbib68","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1039\/C7RA12810J","type":"journal-article","article-title":"A gold nanoparticle-single-chain fragment variable antibody as an immunoprobe for rapid detection of morphine by dipstick","volume":"8","author":"Gandhi","year":"2018","journal-title":"RSC Adv."},{"key":"nanoac66efbib69","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1016\/j.bios.2009.02.016","type":"journal-article","article-title":"Single chain fragment variable recombinant antibody functionalized gold nanoparticles for a highly sensitive colorimetric immunoassay","volume":"24","author":"Liu","year":"2009","journal-title":"Biosens. Bioelectron."},{"key":"nanoac66efbib70","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1177\/35.11.3655323","type":"journal-article","article-title":"A model of protein-colloidal gold interactions","volume":"35","author":"De Roe","year":"1987","journal-title":"J. Histochem. Cytochem."},{"key":"nanoac66efbib71","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s12551-016-0218-6","type":"journal-article","article-title":"Dynamic light scattering: a practical guide and applications in biomedical sciences","volume":"8","author":"Stetefeld","year":"2016","journal-title":"Biophys. Rev."},{"key":"nanoac66efbib72","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1002\/jps.22008","type":"journal-article","article-title":"Formulation development of antibodies using robotic system and high-throughput laboratory (HTL)","volume":"99","author":"Zhao","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"nanoac66efbib73","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jchromb.2004.01.029","type":"journal-article","article-title":"Aggregation and denaturation of antibodies: a capillary electrophoresis, dynamic light scattering, and aqueous two-phase partitioning study","volume":"807","author":"Bermudez","year":"2004","journal-title":"J. Chromatogr. B"},{"key":"nanoac66efbib74","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1023\/B:PHAM.0000032993.98705.73","type":"journal-article","article-title":"Opalescent appearance of an IgG1 antibody at high concentrations and its relationship to noncovalent association","volume":"21","author":"Sukumar","year":"2004","journal-title":"Pharm. Res."},{"key":"nanoac66efbib75","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ab.2008.03.050","type":"journal-article","article-title":"Online fluorescent dye detection method for the characterization of immunoglobulin G aggregation by size exclusion chromatography and asymmetrical flow field flow fractionation","volume":"378","author":"Hawe","year":"2008","journal-title":"Anal. Biochem."},{"key":"nanoac66efbib76","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.3390\/molecules24142620","type":"journal-article","article-title":"Cyclization of single-chain Fv antibodies markedly suppressed their characteristic aggregation mediated by inter-chain VH-VL interactions","volume":"24","author":"Yamauchi","year":"2019","journal-title":"Molecules"},{"key":"nanoac66efbib77","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4314\/tjpr.v12i2.20","type":"journal-article","article-title":"Effect of zeta potential on the properties of nano-drug delivery systems-a review (Part 2)","volume":"12","author":"Honary","year":"2013","journal-title":"Tropical J. Pharm. Res."},{"key":"nanoac66efbib78","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.1039\/C3RA22739A","type":"journal-article","article-title":"PEGylated gold nanoparticles: polymer quantification as a function of PEG lengths and nanoparticle dimensions","volume":"3","author":"Rahme","year":"2013","journal-title":"RSC Adv."},{"key":"nanoac66efbib79","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1002\/app.27767","type":"journal-article","article-title":"Gold\/chitosan\/pluronic composite nanoparticles for drug delivery","volume":"108","author":"Oh","year":"2008","journal-title":"J. Appl. Polym. Sci."},{"key":"nanoac66efbib80","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1016\/j.biomaterials.2008.12.038","type":"journal-article","article-title":"Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice","volume":"30","author":"Zhang","year":"2009","journal-title":"Biomaterials"},{"key":"nanoac66efbib81","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s13404-011-0015-8","type":"journal-article","article-title":"Polyethylene glycol functionalized gold nanoparticles: the influence of capping density on stability in various media","volume":"44","author":"Manson","year":"2011","journal-title":"Gold Bull."},{"key":"nanoac66efbib82","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1080\/17425247.2016.1182485","type":"journal-article","article-title":"Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications","volume":"13","author":"D\u2019souza","year":"2016","journal-title":"Expert Opin. Drug Delivery"},{"key":"nanoac66efbib83","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.1021\/ma020071d","type":"journal-article","article-title":"Terminal attachment of polyethylene glycol (PEG) chains to a gold electrode surface. cyclic voltammetry applied to the quantitative characterization of the flexibility of the attached PEG chains and of their penetration by mobile PEG chains","volume":"35","author":"Anne","year":"2002","journal-title":"Macromolecules"},{"key":"nanoac66efbib84","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1039\/C39940000801","type":"journal-article","volume":"1994","author":"Brust","year":"1994","journal-title":"J. Chem. Soc., Chem. Commun."},{"key":"nanoac66efbib85","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fbioe.2020.00166","type":"journal-article","article-title":"Recent advances in understanding the protein corona of nanoparticles and in the formulation of \u2018stealthy\u2019 nanomaterials","volume":"8","author":"Rampado","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"nanoac66efbib86","doi-asserted-by":"publisher","first-page":"631753","DOI":"10.1155\/2011\/631753","type":"journal-article","article-title":"Gold nanorod bioconjugates for active tumor targeting and photothermal therapy","volume":"2011","author":"Green","year":"2011","journal-title":"J. Nanotechnol."},{"key":"nanoac66efbib87","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/adma.200401991","type":"journal-article","article-title":"Super-stable, high-quality Fe(3) O(4) dendron-nanocrystals dispersible in both organic and aqueous solutions","volume":"17","author":"Kim","year":"2005","journal-title":"Adv. Mater."},{"key":"nanoac66efbib88","doi-asserted-by":"publisher","first-page":"21016","DOI":"10.1039\/c3ra41873a","type":"journal-article","article-title":"Highly stable PEGylated gold nanoparticles in water: applications in biology and catalysis","volume":"3","author":"Rahme","year":"2013","journal-title":"RSC Adv."},{"key":"nanoac66efbib89","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12989-015-0085-5","type":"journal-article","article-title":"Oral absorption of PEG-coated versus uncoated gold nanospheres: does agglomeration matter\u00a0?\u00a0","volume":"12","author":"Hinkley","year":"2015","journal-title":"Part. Fibre Toxicol."},{"key":"nanoac66efbib90","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1166\/jbn.2014.1813","type":"journal-article","article-title":"Pegylation increases platelet biocompatibility of gold nanoparticles","volume":"10","author":"Santos-Martinez","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"key":"nanoac66efbib91","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ejpb.2019.02.013","type":"journal-article","article-title":"Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice","volume":"137","author":"Luan","year":"2019","journal-title":"Eur. J. Pharm. Biopharmaceuticsk"},{"key":"nanoac66efbib92","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.2147\/IJN.S192520","type":"journal-article","article-title":"Development of anisamide-targeted PEGylated gold nanorods to deliver epirubicin for chemo-photothermal therapy in tumor-bearing mice","volume":"14","author":"Wang","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"nanoac66efbib93","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1166\/jbn.2014.1855","type":"journal-article","article-title":"Pegylated glucose gold nanoparticles for improved in-vivo bio-distribution and enhanced radiotherapy on cervical cancer","volume":"10","author":"Geng","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"key":"nanoac66efbib94","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1007\/s11051-013-1694-2","type":"journal-article","article-title":"Gold nanoparticles: role of size and surface chemistry on blood protein adsorption","volume":"15","author":"Benetti","year":"2013","journal-title":"J. Nanopart. Res."},{"key":"nanoac66efbib95","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3109\/17435390.2012.655342","type":"journal-article","article-title":"Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses","volume":"7","author":"Deng","year":"2012","journal-title":"Nanotoxicology"},{"key":"nanoac66efbib96","doi-asserted-by":"publisher","first-page":"031003","DOI":"10.1116\/1.4994286","type":"journal-article","article-title":"Influence of different cleaning processes on the surface chemistry of gold nanoparticles","volume":"12","author":"La Spina","year":"2017","journal-title":"Biointerphases"},{"key":"nanoac66efbib97","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1100\/2011\/768350","type":"journal-article","article-title":"Activation of neutrophils by nanoparticles","volume":"11","author":"Goncalves","year":"2011","journal-title":"ScientificWorldJournal"},{"key":"nanoac66efbib98","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1080\/21691401.2018.1468769","type":"journal-article","article-title":"The effects of gold nanoparticles on the human blood functions","volume":"46","author":"He","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"nanoac66efbib99","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00011-017-1078-7","type":"journal-article","article-title":"Evaluation of the in vitro and in vivo proinflammatory activities of gold (+) and gold (\u2212) nanoparticles","volume":"66","author":"Durocher","year":"2017","journal-title":"Inflammation Res."},{"key":"nanoac66efbib100","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijpharm.2016.05.027","type":"journal-article","article-title":"Bioconjugated gold nanoparticles enhance cellular uptake: a proof of concept study for siRNA delivery in prostate cancer cells","volume":"509","author":"Guo","year":"2016","journal-title":"Int. J. Pharm."},{"key":"nanoac66efbib101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1201\/b10970","type":"book","article-title":"Hemocompatibility of nanoparticles","author":"Evani","year":"2011"},{"key":"nanoac66efbib102","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.ijbiomac.2015.11.031","type":"journal-article","article-title":"Dibutyrylchitin nanoparticles as novel drug carrier","volume":"82","author":"Jain","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"nanoac66efbib103","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1021\/nl0805615","type":"journal-article","article-title":"Method for analysis of nanoparticle hemolytic properties in vitro","volume":"8","author":"Dobrovolskaia","year":"2008","journal-title":"Nano Lett."},{"key":"nanoac66efbib104","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1021\/nn103077k","type":"journal-article","article-title":"Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects","volume":"5","author":"Zhao","year":"2011","journal-title":"ACS Nano"},{"key":"nanoac66efbib105","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1021\/bc049951i","type":"journal-article","article-title":"Toxicity of gold nanoparticles functionalized with cationic and anionic side chains","volume":"15","author":"Goodman","year":"2004","journal-title":"Bioconjug Chem."},{"key":"nanoac66efbib106","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1109\/20.951343","type":"journal-article","article-title":"Optical absorbance of hemoglobin and red blood cell suspensions under magnetic fields","volume":"37","author":"Iwasaka","year":"2001","journal-title":"IEEE Trans. Magn."}],"container-title":["Nanotechnology"],"original-title":[],"link":[{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ac66ef","content-type":"text\/html","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ac66ef\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ac66ef","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ac66ef\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ac66ef\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ac66ef\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ac66ef\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"similarity-checking"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ac66ef\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:11:16Z","timestamp":1762607476000},"score":1,"resource":{"primary":{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ac66ef"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":106,"journal-issue":{"issue":"31","published-online":{"date-parts":[[2022,5,11]]},"published-print":{"date-parts":[[2022,7,30]]}},"URL":"https:\/\/doi.org\/10.1088\/1361-6528\/ac66ef","relation":{},"ISSN":["0957-4484","1361-6528"],"issn-type":[{"value":"0957-4484","type":"print"},{"value":"1361-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"assertion":[{"value":"Human blood biocompatibility and immunogenicity of scFvD2B PEGylated gold nanoparticles","name":"article_title","label":"Article Title"},{"value":"Nanotechnology","name":"journal_title","label":"Journal Title"},{"value":"paper","name":"article_type","label":"Article Type"},{"value":"\u00a9 2022 IOP Publishing Ltd. All rights, including for text and data mining, AI training, and similar technologies, are reserved.","name":"copyright_information","label":"Copyright Information"},{"value":"2022-01-15","name":"date_received","label":"Date Received","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2022-04-13","name":"date_accepted","label":"Date Accepted","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2022-05-11","name":"date_epub","label":"Online publication date","group":{"name":"publication_dates","label":"Publication dates"}}]}}